Breaking News, Promotions & Moves

Neurocrine Biosciences Appoints SVP of Drug Development, Delivery and Device

Dr. Andrew Ratz joins Neurocrine after a 28-year career at Eli Lilly and Company.

Author Image

By: Charlie Sternberg

Associate Editor

Andrew Ratz, Ph.D.

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and Device. In this role, Ratz will lead the transformation of Neurocrine’s Chemistry, Manufacturing and Controls organization to meet the needs of the company’s growing research and development portfolio. “Andy brings unparalleled leadership and experience to Neurocrine’s R&D team,” Neurocrine Biosciences Chief Scientific Officer Jude Onyia,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters